Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Nov 2;22(1):362.
doi: 10.1186/s12882-021-02559-9.

Kidney biopsy in very elderly patients: indications, therapeutic impact and complications

Affiliations
Multicenter Study

Kidney biopsy in very elderly patients: indications, therapeutic impact and complications

Mathilde Fedi et al. BMC Nephrol. .

Abstract

Background: Few data is available on the risk/benefit balance of native kidney biopsy (KB) in very elderly patients.

Methods: Multicenter retrospective cohort study in the Aix-Marseille area: the results of KB and medical charts of all patients over 85 years biopsied between January 2010 and December 2018 were reviewed.

Results: 104 patients were included. Median age was 87 years. Indications for KB were: acute kidney injury (AKI) in 69.2% of patients, nephrotic syndrome (NS) with AKI in 13.5%, NS without AKI in 12.5%, and proteinuria in 4.8%. Median serum creatinine was 262 μmol/L, 21% of patients required dialysis at the time of KB. Significant bleeding occurred in 7 (6.7%) patients, requiring blood cell transfusion in 4 (3.8%), and radiological embolization in 1 (1%). The most frequent pathological diagnoses were: non-diabetic glomerular diseases (29.8%, including pauci-immune crescentic glomerulonephritis in 9.6%), hypertensive nephropathy (27.9%), acute interstitial nephritis (16.3%), renal involvement of hematological malignancy (8.7%), and acute tubular necrosis (6.7%). After KB, 51 (49%) patients received a specific treatment: corticosteroids (41.3%), cyclophosphamide (6.7%), rituximab (6.7%), bortezomib (3.8%), other chemotherapies (3.8%). Median overall survival was 31 months.

Conclusions: KB can reveal a diagnosis with therapeutic impact even in very elderly patients. Severe bleeding was not frequent in this cohort, but KB may have not been performed in more vulnerable patients.

Keywords: Acute kidney injury; Advanced age; Adverse events; Elderly patient; Glomerulonephritis; Kidney biopsy; Nephrotic syndrome; Pathology; Survival; Treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Indication for kidney biopsy in the 104 very elderly patients. (AKI, acute kidney injury; NS, nephrotic syndrome; PU, proteinuria)
Fig. 2
Fig. 2
Patient outcome
Fig. 3
Fig. 3
Kaplan Meier survival analyses. A) Overall survival. B) Renal survival

References

    1. Rule AD. The association between age and Nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med. 2010;152:561. doi: 10.7326/0003-4819-152-9-201005040-00006. - DOI - PMC - PubMed
    1. Nie P, Chen R, Luo M, Dong C, Chen L, Liu J, Hu L, Li B, Luo P. Clinical and pathological analysis of 4910 patients who received renal biopsies at a single Center in Northeast China. Biomed Res Int. 2019;2019:1–9. - PMC - PubMed
    1. Aucella F, Corsonello A, Leosco D, Brunori G, Gesualdo L, Antonelli-Incalzi R. Beyond chronic kidney disease: the diagnosis of renal disease in the elderly as an unmet need. A position paper endorsed by Italian Society of Nephrology (SIN) and Italian Society of Geriatrics and Gerontology (SIGG) J Nephrol. 2019;32:165–176. doi: 10.1007/s40620-019-00584-4. - DOI - PMC - PubMed
    1. Le rapport du REIN 2018 est en ligne - Agence de la biomédecine [Internet]. 2020. https://www.agence-biomedecine.fr/IMG/pdf/rapport_rein_2018_v2.pdf.
    1. Sevillano AM, Diaz M, Caravaca-Fontán F, Barrios C, Bernis C, Cabrera J, Calviño J, Castillo L, Cobelo C, Delgado-Mallén P, Espinosa M, Fernandez-Juarez G, Fernandez-Reyes MJ, Garcia-Osuna R, Garcia P, Goicoechea M, Gonzalez-Cabrera F, Guzmán DA, Heras M, Martín-Reyes G, Martinez A, Olea T, Peña JK, Quintana LF, Rabasco C, López Revuelta K, Rodas L, Rodriguez-Mendiola N, Rodriguez E, San Miguel L, de la Nieta MD S, Shabaka A, Sierra M, Valera A, Velo M, Verde E, Ballarin J, Noboa O, Moreno JA, Gutiérrez E, Praga M. On behalf of the Spanish Group for the Study of Glomerular Diseases (GLOSEN): IgA nephropathy in elderly patients. Clin J Am Soc Nephrol. 2019;14:1183–1192. doi: 10.2215/CJN.13251118. - DOI - PMC - PubMed

Publication types